The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Aquaculture
Marine Biotechnology
The road to successful DNA vaccination of Atlantic salmon against virus diseases
National Programme
National
Børre Robertsen
borre.robertsen@uit.no
UiT - The Arctic University of Norway (Norway)
NA
2016
2018
€ 360,000
https://prosjektbanken.forskningsradet.no/project/FORISS/254907?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=180&ProgAkt.3=HAVBRUK2-Stort%20program%20for%20havbruksforskning&source=FORISS&projectId=269015
Farmed Atlantic salmon is attacked by several pathogenic viruses, which represent a continuous threat for the aquaculture industry. Vaccines based on inactivated virus are available for some diseases like PD, but do not give satisfactory protection. Vaccines against the viruses causing heart skeletal and muscle inflammation and cardiomyopathy syndrome are not available because the viruses cannot yet be grown in cell culture. Our group is working on DNA vaccines because they are independent of virus culture and because they give a very high level of protection of salmonids against rhabdovirus infection. While DNA vaccines against other salmon viruses have previously shown rather modest protection, our group has recently shown that a very high level of protection can be obtained with a DNA-vaccine against infectious salmon anemia virus (ISAV) using interferon (IFN) as an adjuvant. A DNA-vaccine is a plasmid expressing the surface protein of the virus, which is injected into the fish muscle. A plasmid expressing IFN is co-injected as adjuvant. IFN is a protein that has a critical role in immunity against viruses. Our recent work suggests that the properties of the virus antigen are very important for the effect of IFN as adjuvant. In this project we are going to study more closely the role of IFN in DNA vaccination against PD-virus and the molecular signature of immune genes induced by the DNA vaccine against PD. We are also going to investigate how subcellular location of virus protein antigens influences the immune response of DNA vaccines. The overall goal is to develop a concept for DNA vaccines that works well against a broad spectrum of salmon viruses.
Vaccines development; Fish health; Disease; Salmon; Fish;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */